Galectin-3 and soluble ST2 and kidney function decline in older adults: The Cardiovascular Health Study (CHS)

American Journal of Kidney Diseases

Volumn 67, Issue 6, 2016, Pages 994-996

  Bansal, Nisha ^a   Katz, Ronit ^a   Seliger, Stephen ^b   Defilippi, Christopher ^b   Sarnak, Mark J ^c   Delaney, Joseph A ^a   Christenson, Robert ^b   De Boer, Ian H ^a   Kestenbaum, Bryan ^a   Robinson Cohen, Cassianne ^a   Ix, Joachim H ^d   Shlipak, Michael G ^e  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

^c TUFTS MEDICAL CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BIOLOGICAL MARKER; CREATININE; CYSTATIN C; GALECTIN 3; SOLUBLE ST2 PROTEIN; TROPONIN T; UNCLASSIFIED DRUG; IL1RL1 PROTEIN, HUMAN; INTERLEUKIN 1 RECEPTOR LIKE 1 PROTEIN;

CARDIAC MUSCLE CELL; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; GLOMERULUS FILTRATION RATE; HEART FAILURE; HEART MUSCLE FIBROSIS; HIGH RISK PATIENT; HUMAN; KIDNEY DYSFUNCTION; LETTER; AGED; BLOOD; COHORT ANALYSIS; FEMALE; LONGITUDINAL STUDY; MALE; PROGNOSIS; RENAL INSUFFICIENCY, CHRONIC; STATISTICAL MODEL;

AGED; COHORT STUDIES; CREATININE; CYSTATIN C; FEMALE; GALECTIN 3; GLOMERULAR FILTRATION RATE; HUMANS; INTERLEUKIN-1 RECEPTOR-LIKE 1 PROTEIN; LOGISTIC MODELS; LONGITUDINAL STUDIES; MALE; PROGNOSIS; RENAL INSUFFICIENCY, CHRONIC;

EID: 84955571630     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2015.12.022     Document Type: Letter

References (13)

1. T.J. Wang, K.C. Wollert, M.G. Larson, and et al. Prognostic utility of novel biomarkers of cardiovascular stress: the Framingham Heart Study Circulation 126 2012 1596 1604
2. J.E. Ho, C. Liu, A. Lyass, and et al. Galectin-3, a marker of cardiac fibrosis, predicts incident heart failure in the community J Am Coll Cardiol 60 2012 1249 1256
3. U.C. Sharma, S. Pokharel, T.J. van Brakel, and et al. Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction Circulation 110 2004 3121 3128
4. E.O. Weinberg, M. Shimpo, S. Hurwitz, S. Tominaga, J.L. Rouleau, and R.T. Lee Identification of serum soluble ST2 receptor as a novel heart failure biomarker Circulation 107 2003 721 726
5. J.E. Ho, S.J. Hwang, K.C. Wollert, and et al. Biomarkers of cardiovascular stress and incident chronic kidney disease Clin Chem 59 2013 1613 1620
6. C.M. O'Seaghdha, S.J. Hwang, J.E. Ho, R.S. Vasan, D. Levy, and C.S. Fox Elevated galectin-3 precedes the development of CKD J Am Soc Nephrol 24 2013 1470 1477
7. L.A. Inker, C.H. Schmid, H. Tighiouart, and et al. Estimating glomerular filtration rate from serum creatinine and cystatin C N Engl J Med 367 2012 20 29
8. N. Bansal, R. Katz, L. Dalrymple, and et al. NT-proBNP and troponin T and risk of rapid kidney function decline and incident CKD in elderly adults Clin J Am Soc Nephrol 10 2 2015 205 214
9. C. Drechsler, G. Delgado, C. Wanner, and et al. Galectin-3, renal function, and clinical outcomes: results from the LURIC and 4D studies J Am Soc Nephrol 26 9 2015 2213 2221
10. L. Calvier, E. Martinez-Martinez, M. Miana, and et al. The impact of galectin-3 inhibition on aldosterone-induced cardiac and renal injuries JACC Heart Fail 3 2015 59 67
11. A.R. Frenay, L. Yu, A.R. van der Velde, and et al. Pharmacological inhibition of galectin-3 protects against hypertensive nephropathy Am J Physiol Renal Physiol 308 2015 F500 F509
12. Y.C. Tung, C.H. Chang, Y.C. Chen, and P.H. Chu Combined biomarker analysis for risk of acute kidney injury in patients with ST-segment elevation myocardial infarction PLoS One 10 2015 e0125282
13. S. Bruneau, L. Le Berre, C. Herve, and et al. Potential role of soluble ST2 protein in idiopathic nephrotic syndrome recurrence following kidney transplantation Am J Kidney Dis 54 2009 522 532